Università LUM Giuseppe Degennaro - sito della Ricerca Institutional Research Information System

LEGGE, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.995
AS - Asia 1.252
EU - Europa 390
Continente sconosciuto - Info sul continente non disponibili 121
AF - Africa 118
SA - Sud America 71
OC - Oceania 2
Totale 3.949
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.959
SG - Singapore 720
CN - Cina 385
IT - Italia 158
MA - Marocco 110
DE - Germania 94
BR - Brasile 53
PK - Pakistan 36
HK - Hong Kong 27
VN - Vietnam 25
FR - Francia 23
PL - Polonia 23
GB - Regno Unito 22
NL - Olanda 20
BD - Bangladesh 14
CA - Canada 14
CZ - Repubblica Ceca 11
JP - Giappone 10
IN - India 9
MX - Messico 9
ES - Italia 7
JM - Giamaica 7
LT - Lituania 6
TR - Turchia 6
UA - Ucraina 6
EC - Ecuador 5
FI - Finlandia 5
SE - Svezia 5
ID - Indonesia 4
AR - Argentina 3
EG - Egitto 3
VE - Venezuela 3
ZA - Sudafrica 3
AM - Armenia 2
AZ - Azerbaigian 2
CO - Colombia 2
HR - Croazia 2
PT - Portogallo 2
RU - Federazione Russa 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AT - Austria 1
AU - Australia 1
BO - Bolivia 1
BS - Bahamas 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
MD - Moldavia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
PW - Palau 1
PY - Paraguay 1
SC - Seychelles 1
SV - El Salvador 1
TJ - Tagikistan 1
TL - Timor Orientale 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 3.828
Salva come PNG Salva come JPEG
Città #
San Jose 451
Dallas 362
Singapore 319
Ashburn 276
The Dalles 127
Hefei 121
Casablanca 107
San Francisco 88
Munich 72
Council Bluffs 52
Islamabad 36
Chicago 33
Los Angeles 31
New York 29
Santa Clara 29
Hillsboro 25
Hong Kong 24
Warsaw 22
Phoenix 21
Chardon 18
Oxnard 18
Atlanta 17
Beijing 16
Rome 15
Amsterdam 14
Frankfurt am Main 14
Milan 14
Naples 12
Orem 11
Boston 10
Ho Chi Minh City 10
London 10
Tokyo 10
Brno 9
Brooklyn 9
Princeton 8
Reston 7
Bari 6
Bologna 6
Boydton 6
Charlotte 6
Mexico City 6
Seattle 6
São Paulo 6
Chennai 5
Kingston 5
Stockholm 5
Turin 5
Abbeville 4
Paris 4
Ankara 3
Cagliari 3
Catania 3
Clifton 3
Denver 3
Florence 3
Genoa 3
Guayaquil 3
Haiphong 3
Marrakesh 3
Miami 3
Montreal 3
Poplar 3
Queens 3
San Diego 3
The Bronx 3
Toronto 3
Turku 3
Verona 3
Baku 2
Barnet 2
Biên Hòa 2
Bogotá 2
City of London 2
Cleveland 2
Cuiabá 2
Hanoi 2
Johannesburg 2
Kansas City 2
Las Cruces 2
Limburg an der Lahn 2
Monza 2
Nola 2
Olomouc 2
Orlando 2
Padua 2
Palermo 2
Poughkeepsie 2
St Petersburg 2
Tappahannock 2
Trento 2
Venice 2
Yerevan 2
Zagreb 2
Ahmedabad 1
Aiken 1
Akron 1
Alexandria 1
Alfenas 1
Alghero 1
Totale 2.630
Salva come PNG Salva come JPEG
Nome #
Biologia e genetica molecolare in ginecologia ed ostetricia 54
A case of drug resistant clear cell ovarian cancer showing responsiveness to gemcitabine at first administration and at re-challenge 54
Celecoxib modulates the expression of cyclooxygenase-2, Ki67, apoptosis-related marker, and microvessel density in human cervical cancer: A pilot study 52
Carboplatin (C) plus paclitaxel (P) versus carboplatin plus pegylated liposomal doxorubicin (PLD) in patients with advanced ovarian cancer (AOC): final analysis of the MITO-2 randomized multicenter trial 49
Angiogenesis inhibitors in gynecological cancers 48
Carboplatin (C) plus paclitaxel (P) versus carboplatin plus pegylated liposomal doxorubicin (PLD) as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III 48
Analysis of survivin expression in ovarian cancer and its correlation with clinical, surgical, pathological and apoptosis-related parameters 48
BRCA1-related malignancies in a family presenting with von Recklinghausen's disease 48
A prospective multicentric study of risk-reducing salpingo-oophorectomy in BRCA mutation patients 47
Advances in surgical management of cervical cancer 47
Celecoxib plus carboplatin in heavily pre-treated patients with recurrent ovarian carcinoma: preliminary results of a phase II study 46
Anatomical distribution of sentinel lymph nodes in patients with endometrial cancer: a multicenter study 45
[Familial ovarian carcinoma] 44
Analysis of cyclooxygenase-2 (COX-2) expression in different sites of endometriosis and correlation with clinicopathological parameters 43
Preoperative concomitant chemoradiotherapy in locally advanced cervical cancer: Safety, outcome, and prognostic measures 43
Biologia e genetica molecolare in ginecologia ed ostetricia 43
Celecoxib modulates angiogenesis-related parameters in both sera and tumor biopsies from cervical cancer patients 42
Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study 42
[Biological factors with prognostic significance in ovarian cancer]. Fattori biologici con significato prognostico nel cancro ovarico 42
Biological characterization of ovarian cancer: prognostic and therapeutic implications 42
Tumori maligni della cervice uterina 41
Ruolo dell'isterectomia laparoscopica nel trattamento del carcinoma della cervice uterina 40
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 40
Whose surgery is this? Endometriosis of the round ligament 39
Nerve-sparing laparoscopic colposacropexy using a percutaneous surgical system: a case report 39
Cyclooxygenase-2 (COX-2) expression in non neoplastic (NNED) and  neoplastic vulvar epithelial disorders 39
Comparison of Different Surgical Approaches for Stage IB1 Cervical Cancer Patients: A Multi-institution Study and a Review of the Literature 37
Clinical outcome of recurrent endometrial cancer: analysis of post-relapse survival by pattern of recurrence and secondary treatment 37
Targeted therapy for ovarian cancer 36
Magnetic resonance imaging of pelvic endometriosis. Effect of reader's experience on accuracy and interobserver variability 36
Impact of pattern of recurrence on clinical outcome of ovarian cancer patients: Clinical considerations 36
Tumori maligni della cervice uterina 36
Robotic Surgery in Elderly and Very Elderly Gynecologic Cancer Patients 36
Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: proof of a concept 35
Laparoscopic versus robotic hysterectomy in obese and extremely obese patients with endometrial cancer: A multi-institutional analysis 35
Risk Assessment Model for Complications in Minimally Invasive Hysterectomy: A Pilot Study 35
Transplacental carcinogenesis: state of the art 35
Prospettive future per i tumori della cervice uterina 35
Laparoscopic sacrocolpopexy versus pelvic organ prolapse suspension for surgical management of pelvic organ prolapse: a retrospective study 35
Epithelial ovarian cancer relapsing as isolated lymph node disease: natural history and clinical outcome 35
Cyclooxygenase-2 expression in endometrial carcinoma - Correlation with clinicopathologic parameters and clinical outcome 34
Postoperative concomitant boost radiotherapy in high risk endometrial cancer 34
Intensity-modulated extended field chemoradiation plus simultaneous integrated boost in the preoperative treatment of locally advanced cervical cancer: a dose-escalation study 34
Expression of surviving in locally advanced cervical cancer (LACC) patients administered chemoradiation (CT/RT) followed by radical surgery (RS): prediction of response and clinical outcome 34
Targeted therapies in gynecological cancers 34
Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients. 34
Cyclooxygenase-2 (COX-2) inhibition is associated with increased proportion of Tumor Infiltrating Lymphocytes (TIL) expressing the zeta chain of T-Cell Receptor (TCR) in human cervical cancer 34
Clinical role of Cyclooxygenase-2 (COX-2) expression in tumor and stromal component of cervical cancer 33
Tamoxifen modulates the expression of Ki67, apoptosis, and microvessel density in cervical cancer 33
Clinical outcome of recurrent locally advanced cervical cancer (LACC) submitted to primary multimodality therapies 33
Fattori prognostici nel carcinoma ovarico epiteliale 33
Large-field pre-operative chemoradiation in locally advanced carcinoma of the cervix: preliminary results of a phase I study (LARA-CC-1) 33
Expression of cyclooxygenase-2 (COX-2) in non-neoplastic and neoplastic vulvar epithelial lesions 33
Cyclooxygenase-2 expression in lymph node metastasis of cervical and vulvar cancer 33
Simultaneous integrated boost volumetric modulated Arc therapy in the postoperative treatment of high-risk to intermediate-risk endometrial cancer: results of ADA II phase I-II trial 33
Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study 33
Prognostic role of the ratio between cyclooxygenase-2 (COX-2) in tumor and stroma compartments in cervical cancer 33
Laparoscopic en bloc right diaphragmatic peritonectomy for diaphragmatic endometriosis according to the Sugarbaker technique 32
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: Feasibility and clinical results 32
Radical surgery (RS) plus intraperitoneal hyperthermic perfusion (IPHP) with oxaliplatin followed by intravenous docetaxel in the treatment of peritoneal carcinosis from platinum-sensitive recurrent ovarian cancer (OC): A pilot study 32
Laparoscopic vs transvaginal cuff closure after total laparoscopic hysterectomy: a randomized trial by the Italian Society of Gynecologic Endoscopy 32
Intensified pre-operative chemoradiation in locally advanced carcinoma of the uterine cervix: final resultsof a phase I-II study (ESTER-1) 31
COX-2 inhibition in gynaecological cancers 31
Completion surgery after concomitant chemoradiation in locally advanced cervical cancer: a comprehensive analysis of pattern of postoperative complications 31
Progestin-realising intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment 31
New insights in biological characterization of ovarian cancer 31
Minimally Invasive Approaches in Locally Advanced Cervical Cancer Patients Undergoing Radical Surgery After Chemoradiotherapy: A Propensity Score Analysis 31
Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients 31
The peritoneal cavity: tumor metastasis and growth 31
Completion surgery after concomitant chemoradiation in obese women with locally advanced cervical cancer: Evaluation of toxicity and outcome measures 30
Verso la classificazione molecolare dei tumori: possibili implicazioni prognostiche e terapeutiche 30
Prognostic role of the ratio between cyclooxygenase-2 (COX-2) in tumor and stroma compartments in cervical cancer 30
Endometriosis and Cancer 30
Phase II study on Pemetrexed in advanced and/or recurrent cervical cancer patients: a MITO study 30
Comparison of absorbable and permanent sutures for laparoscopic sacrocervicopexy: A randomized controlled trial 30
Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2/neu expression in ovarian cancer 29
Tumori dell'ovaio 29
Locally advanced cervical carcinoma patients treated with chemoradiation followed by radical surgery: clinical response and oncological outcomes according to histotype after propensity score analysis Eur J Surg Oncol 29
Laparoscopic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective, Phase II Study 29
Which role for pre-treatment laparoscopic staging? 29
Il carcinoma ovarico familiare 29
Ovarian cancer patients with "node-positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA/B 29
Expression of cyclooxygenase-2 (COX-2) in tumour and stroma compartments in cervical cancer: clinical implications 28
Neoadjuvant therapy changes the lymphocyte composition of tumor-draining lymph nodes in cervical carcinoma 28
Phase II study of oxaliplatin (OXA) and docetaxel (DTX) in recurrent ovarian cancer 28
Cyclooxygenase-2 (COX-2) expression in locally advanced cervical cancer patients undergoing chemoradiation plus surgery 28
Role of minimally invasive surgery versus open approach in patients with early-stage uterine carcinosarcomas: a retrospective multicentric study 28
From bio-molecular and technology innovations to clinical practice: focus on ovarian cancer 28
Prognostic factors in clear cell carcinoma of endometrium: analysis of 55 cases 28
Indicatori molecolari prognostici e predittivi di risposta nel carcinoma ovarico 28
Proposal of a prognostic score in combined modality treatment of locally advanced carcinoma of the uterine cervix 28
Novel VEGF-independent Strategies Targeting Tumor Vasculature: Clinical Aspects 28
Cyclooxygenase-2 expression in borderline ovarian tumors 28
Prolonged Chemoradiation in Locally Advanced Carcinoma of the Uterine Cervix Final Results of a Phase II Study (ESTER-1) 28
Is there a prognostic role for the pattern of recurrence in platinum-sensitive relapsing ovarian cancer patients? 27
New drugs in ovarian cancer 26
Lymphocyte composition of tumor draining lymph nodes from cervical and endometrial cancer patients 26
Celecoxib, a selective cyclooxygenase-2 (COX-2) inhibitor, modulates cytokines levels in serum of cervical cancer patients 26
Nuovi Fattori Biologici di Prognosi nel Carcinoma dell'Endometrio 26
Comparison Between Laparoscopic and Robotic Surgery in Elderly Patients With Endometrial Cancer: A Retrospective Multicentric Study 26
Totale 3.484
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.115
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.115
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/2024203 0 0 0 121 9 2 0 1 24 30 4 12
2024/2025659 19 48 40 24 74 2 1 24 193 13 110 111
2025/20262.508 95 371 221 261 55 109 642 227 156 259 49 63
2026/2027579 39 33 215 292 0 0 0 0 0 0 0 0
Totale 3.949